Esansiyel Hipertansiyonda Nötrofil-Lenfosit Oranı ve Hipertansif Retinopati Arasındaki İlişki

Year 2019, Volume: 5 Issue: 2, 209 - 214, 01.01.2019

Mustafa Karaca

Abstract

Amaç: Daha önceden yapılan çalışmalar artmış nötrofil lenfosit oranlarının sistemik inflamasyonun bir göstergesi olduğunu göstermiştir. Hipertansiyon, kardiyovasküler risk ve sistemik hedef organ hasarı ile ilişkilidir. Hipertansif retinopati HR hipertansiyonun en sık görülen göz komplikasyonudur. HR’nin patofizyolojik mekanizmaları henüz tam olarak belirlenememiştir. Kan basıncı yüksekliği retinopatinin patogenezini tek başına tamamen açıklayamaz, sistemik inflamasyon gibi diğer patofizyolojik mekanizmalar da ilgili olabilir. Bundan dolayı, bu çalışma şu sorulara cevap bulmak amacıyla yapıldı; i HR’de NLR düzeyi değişir mi ? ii HR evresi ile NLR düzeyleri arasında bir ilişki var mıdır?Gereç ve Yöntemler: Çalışmaya HR’si olan 92 hipertansiyon hastası alındı. Hipertansif hastalar Keith- Wagener sınıflandırmasına göre iki gruba ayrıldı. Grup 1 evre 1 HR’si olan 46 hastadan, Grup 2 evre 2 HR’si olan 46 hastadan oluşturuldu. Kontrol grubu olarak, yaş, cinsiyet ve vücut kitle indeksi açısından benzer 46 sağlıklı kişi alındı.Bulgular: Grup 2’deki NLR düzeyi Grup 1’dekinden 32,06±4,88 karşı 29,54±3,05, p

Keywords

Hipertansiyon, Hipertansif retinopati, Nötrofil lenfosit oranı, Sistemik inflamasyon

The Association Between the Neutrophil to Lymphocyte Ratio and Hypertensive Retinopathy in Essential Hypertension

Abstract

Objective: Previous studies have shown that an elevated neutrophil lymphocyte ratio NLR is indicative of systemic inflammation. Hypertension is associated with cardiovascular risk and systemic target organ damage. Hypertensive retinopathy HR is the most common ocular complication of hypertension. The pathophysiological mechanism of HR is not fully established. Elevated blood pressure alone does not fully account for the extent of retinopathy, and other pathophysiological mechanisms such as systemic inflammation may be involved. Therefore, this study was designed to answer the following questions; i Do NLR levels change in HR? ii Is there any relation between the degree of HR and NLR levels?Material and Methods: This study included 92 hypertensive patients with HR. The hypertensive patients were divided into two groups according to the Keith-Wagener classification. Group 1 comprised 46 patients with grade I HR, and Group 2 comprised 46 patients with grade II HR. We selected 46 healthy subjects matched for age, sex, and body mass index for the control group.Results: The level of NLR in Group 2 was significantly higher than in Group 1 32,06±4,88 vs 29,54±3,05, p

Keywords

Hypertension, Hypertensive retinopathy, Neutrophil lymphocyte ratio, Systemic inflammation

References

• Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002;252: 283-94.
• Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: An epidemiologic view. Blood Coagul Fibrinolysis 1999;10:S9-S12.
• Rifai N. C-reactive protein and coronary heart disease: diagnostic and therapeutic implications for primary prevention. Cardiovasc Toxicol 2001;1:153-7.
• Benzaquen LR, Yu H, Rifai N. High sensitivity C-reactive protein: An emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci 2002;39:459-97.
• Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 2003; 92(4B): 17K-22K.
• Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 2012;5:2.
• Guo X, Zhang S, Zhang Q, et al. Neutrophil:lymphocyte ratio is positively related to type 2 diabetes in a large-scale adult population: A Tianjin Chronic Low-Grade Systemic Inflammation and health cohort study. Eur J Endocrinol 2015;173:217-25.
• Demir M. The relationship between neutrophil lymphocyte ratio and non-dipper hypertension. Clin Exp Hypertens 2013;35:570-73i.
• Yilmaz MI, Sonmez A, Kilic S, Celik T, Bingol N, Pinar M, Mumcuoglu T, Ozata M. The association of plasma adiponectin levels with hypertensive retinopathy. Eur J Endocrinol 2005;152:233-40.
• Svardsudd K, Wedel H, Aurell E, Tibblin G. Hypertensive eye ground changes. Prevalence, relation to blood pressure and prognostic importance. The study of men born in 1913. Acta Med Scand 1978;204:159-67.
• Lowenthal MN, Zimlichman R. Resolution of hypertensive retinopathy despite persistent high diastolic pressure. South Med J 1993;86:190-3.
• Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, Sharrett AR, Davis MD, Cai J. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106:2269-80.
• Ebinc H, Ebinc FA, Ozkurt ZN. Relationship of early hypertensive retinopathy to inflammation markers and microalbuminuria in hypertensive patients with regulated blood pressure. Saudi Med J 2007;28:472-3.